S. Debrus

发表

Varicella-zoster virus open reading frame 4 encodes an immediate-early protein with posttranscriptional regulatory properties

P. Defechereux, J. Piette, L. Baudoux, 1997, Journal of virology.

CD28-B7 Costimulatory Blockade by CTLA4Ig Delays the Development of Retrovirus-Induced Murine AIDS

P. Linsley, M. Demoitié, L. de Leval, 1998, Journal of Virology.

Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency sydrome development

L. de Leval, M. Moutschen, P. Lane, 1999, Immunology.

Viral Glycoproteins in Herpesviridae Granulomas

P. Delvenne, A. Nikkels, J. Piette, 1994, The American Journal of dermatopathology.

Varicella-zoster virus latency in the adult rat is a useful model for human latent infection

A. Nikkels, J. Piette, B. Rentier, 1995, Neurology.

Established and new rotavirus vaccines: a comprehensive review for healthcare professionals

B. Benninghoff, S. Debrus, Volker Vetter, 2021, Human vaccines & immunotherapeutics.

Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data

M. Postma, B. Standaert, S. Debrus, 2013, PloS one.

Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase

T. Velu, B. Degrève, J. Balzarini, 2000, Cancer Gene Therapy.

Live Attenuated Human Rotavirus Vaccine, RIX4414, Provides Clinical Protection in Infants Against Rotavirus Strains With and Without Shared G and P Genotypes: Integrated Analysis of Randomized Controlled Trials

R. Ward, A. Bouckenooghe, S. Debrus, 2009, The Pediatric infectious disease journal.

Lessons to be learned from varicella-zoster virus.

S. Schoonbroodt, M. Merville, P. Defechereux, 1996, Veterinary microbiology.

Varicella zoster virus latency in the nervous system of rats and humans accompanied by the abundant expression of an immediate-early protein that is also present in acute infection

A. Nikkels, R. Cohrs, J. Piette, 1996 .

Detection of cytokines in human sural nerve biopsies: an immunohistochemical and molecular study

P. Delvenne, M. Deprez, S. Debrus, 2001, Acta Neuropathologica.

Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein.

S. Schoonbroodt, M. Merville, P. Defechereux, 1996, The Journal of general virology.

Comparative immunohistochemical study of herpes simplex and varicella-zoster infections

P. Delvenne, A. Nikkels, J. Piette, 2005, Virchows Archiv A.

Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections.

P. Delvenne, A. Nikkels, J. Piette, 1996, Journal of clinical pathology.

Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency

A. Nikkels, J. Piette, B. Rentier, 1995, Journal of virology.

Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination

S. Madhi, Y. Lau, T. Vesikari, 2016, Human vaccines & immunotherapeutics.

Distribution of varicella‐zoster virus gpI and gpII and corresponding genome sequences in the skin

P. Delvenne, A. Nikkels, J. Piette, 1995, Journal of medical virology.

Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons.

R. Cohrs, J. Piette, R. Mahalingam, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Immunohistochemical identification of varicella‐zoster virus gene 63‐encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: Implications for diagnostic use

A. Nikkels, J. Piette, G. Piérard, 1995, Journal of medical virology.

Localization of varicella-zoster virus nucleic acids and proteins in human skin

J. Piette, G. Piérard, B. Rentier, 1995, Neurology.

Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix™

G. Dubin, S. Debrus, L. Friedland, 2013, Human vaccines & immunotherapeutics.

Varicella-zoster virus gene regulation

M. Merville, P. Defechereux, J. Piette, 1995, Neurology.

Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.

P. Kinchington, B. Rentier, A. Arvin, 1997, Journal of immunology.

The acidic amino-terminal region of varicella-zoster virus open reading frame 4 protein is required for transactivation and can functionally replace the corresponding region of herpes simplex virus ICP27.

J. Piette, J. Cohen, S. Debrus, 1995, Virology.

Decreased protein levels of the c-Cbl protooncogene in murine AIDS.

S. Rahmouni, M. Moutschen, M. Trebak, 1998, Cellular immunology.

A mathematical model of the indirect effects of rotavirus vaccination

J. Gray, S. Debrus, E. Newbern, 2009, Epidemiology and Infection.

Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.

S. Debrus, I. Smolenov, A. Delem, 2010, The Journal of infectious diseases.

Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414

B. Benninghoff, C. Rodrigo, S. Debrus, 2014, BMC Pediatrics.